ALSO NOTED: Ivax wins FDA approval; Reformulated Clarinex gains regulatory OK; Schwarz buys remaining rotigotine rights; and mu

> The FDA has given Miami-based Ivax final approval for hydrochlorothiazide capsules 12.5 mg. Release

> The FDA has approved a reformulated version of Clarinex for allergies. Release

> Analysts applauded news that Schwarz Pharma had bought out the remaining rights to rotigotine. Story

> Dusa Pharmaceuticals reported lower-than-expected second quarter sales. Release

And Finally... In a new paper in Science, researchers and ethicists discuss the potential ethical dilemmas surrounding the use of monkeys in testing brain cell therapy, such as creating a monkey with a human-like mind. Article

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.